Status:
COMPLETED
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort: The 4F Study
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
HIV Infections
Alcohol Drinking
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to follow a cohort of HIV-infected adults who have alcohol and/or drug use to: 1) test the associations between alcohol (and illicit drugs and polypharmacy (multiple presc...
Detailed Description
Up to a third of middle-aged people living with HIV infection (PLWH) experience falls each year. Falls are the most common cause of non-fatal injury in the US and the cost from emergency department vi...
Eligibility Criteria
Inclusion
- Ability to speak English (fluency)
- Willing to provide information for \>1 contact person likely to know their whereabouts for follow-up.
- Documented HIV antibody by ELISA confirmed by Western Blot or current HIV viral load greater than 10,000 (in any medical record); or HIV antibody by 4th generation ELISA confirmed by a "Multi-Spot" rapid test for discrimination of HIV-1 from HIV-2 infection and, if necessary in the case of discordant results, nucleic acid testing (NAT) for HIV-1; or any other confirmatory pathway approved by the Massachusetts Department of Public Health, U.S. Centers for Disease Control and Prevention or BMC Center for Infectious Diseases.
- Any past 12 month use of illicit drugs, marijuana (not recommended by a healthcare provider), or nonmedical use of prescription medications (assessed using the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS) Tool); OR past 12 month alcohol use with positive AUDIT-C score (≥3 for females and ≥4 for males)
- OR, an existing participant in the Boston ARCH Cohort
Exclusion
- Inability to consent or understand interview (determined by trained research assistant)
- Under age 18
- Plans to leave Boston area in \<1 year
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 27 2023
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT03414411
Start Date
February 20 2018
End Date
April 27 2023
Last Update
June 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University Medical Campus
Boston, Massachusetts, United States, 02118